Speratum Biopharma, Inc.

Houston, United States

At Speratum, we're developing a robust RNAi platform targeting key oncogenic drivers in solid tumors.

$581K raised

Nov 2024

Convertible Note

Biotechnology Health Care Oncology Therapeutics

Top Investors

MassChallenge Carao Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Speratum Biopharma, Inc.

How much funding has Speratum Biopharma, Inc. raised?

Speratum Biopharma, Inc. has raised $581K in total funding. The most recent round was Convertible Note. The last funding was announced in November 2024.

Who are Speratum Biopharma, Inc.'s investors?

Speratum Biopharma, Inc.'s investors include MassChallenge, Carao Ventures.

Where is Speratum Biopharma, Inc. headquartered?

Speratum Biopharma, Inc. is headquartered in Houston, United States.

What does Speratum Biopharma, Inc. do?

At Speratum, we're developing a robust RNAi platform targeting key oncogenic drivers in solid tumors.

What stage is Speratum Biopharma, Inc. at?

Speratum Biopharma, Inc. is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 5, 2024.

MLA

"Speratum Biopharma, Inc. — Funding & Investors." VCBacked, November 5, 2024, https://www.vcbacked.co/company/speratum-biopharma-inc. Accessed July 2, 2026.

APA

VCBacked. (2024). Speratum Biopharma, Inc. — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/speratum-biopharma-inc

Wikipedia (cite web)

{{cite web |title=Speratum Biopharma, Inc. — Funding & Investors |url=https://www.vcbacked.co/company/speratum-biopharma-inc |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 5, 2024.